A world-class specialty biopharmaceutical company

Our ambition is to become a leading specialty biopharmaceutical company meeting the needs of patients around the world. With our market-leading asthma management products and exciting development pipeline of treatments for allergy, asthma and COPD we’re making good progress towards achieving our goal.